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Increasing evidence implies the existence of a visceral pain pathway in the dorsal column
of the spinal cord. Limited midline myelotomy has been used to treat intractable pelvic cancer
pain. However, no obvious evidence has been provided that high cervical punctate midline
myelotomy (CPMM) relieves visceral pain originating from the abdomen. This study was
designed to examine the pain relief effect of CPMM in a mouse model of visceral pain. Thirty-
six Institute of Cancer Research (ICR) mice were divided into three groups: Group 1, healthy
controls; Group 2, treated with CPMM at C1 and C2; and Group 3, a sham group that
underwent laminectomy at C1 and C2 without CPMM. All animals were tested for
antinociception in the writhing test 24 hours after surgery. Visceral pain-related behaviors
were counted from 5–20 minutes after intraperitoneal injection of 0.6% acetic acid. Writhing
test scores were not significantly different between Groups 1 (56.7 ± 10.7) and 3 (50.7 ± 17.4).
However, Group 2 (30.0 ± 14.3) showed more than 40% antinociception after treatment, and
writhing test scores were significantly different from those of Groups 1 and 3 (p < 0.001).
Our results confirm that midline punctate myelotomy can relieve visceral pain and imply
that there is a pathway in the posterior funiculus that signals visceral pain. Punctate midline
myelotomy at the cervical or high thoracic level may be an alternative strategy in the
management of intractable visceral pain due to abdominal or pelvic cancers.
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In spite of the improved use of narcotics and intra-
thecal opioids, oncogenic pain in patients with abdominal
cancer is still difficult to control with medication. In
order to treat such intractable cancer-related pain,
various ablative operations have been proposed.
Although visceral pain is generally thought to be
mediated by the spinothalamic tract and possibly the
spinoreticular tract, it is becoming evident that the
dorsal column plays an important role in the processing
of viscerosensory transmission [1–7]. Al-Chaer et al
demonstrated that a dorsal column lesion is more
effective in controlling visceral pain than a ventrolateral
column lesion [7]. Pain relief following midline
myelotomy in cancer patients provides further
evidence for the existence of a dorsomedially located
visceral pain pathway [8–13]. The antinociceptive effect
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of high cervical punctate midline myelotomy (CPMM)
in the treatment of visceral pain originating from
oncogenic pain in the abdomen and/or pelvis is still
controversial. In order to evaluate the possibility of
using CPMM in releasing intractable cancer-related
visceral pain and to investigate the signaling pathways
of visceral pain, it is necessary to develop an animal
model. Our study was designed to develop a new
animal model to examine the antinociceptive effect of
CPMM in the treatment of visceral pain.
MATERIALS AND METHODS
Animals
A total of 36 male Institute of Cancer Research (ICR)
mice weighing 26–34 g were used in this study. Surgi-
cal and experimental protocols were approved by the
Kaohsiung Medical University Animal Research
Committee. Animals were divided into three groups:
Group 1, healthy controls; Group 2, mice undergoing
CPMM at C1 and C2; and Group 3, sham mice that
underwent laminectomy at C1 and C2 without CPMM.
Surgical preparation
Mice were anesthetized with chloral hydrate (350 mg/kg
i n t r a p e r i t o n e a l l y )  a n d  x y l a z i n e  ( 4  m g / k g
intraperitoneally) in the right lower quadrant of the
abdomen. Animals were subsequently placed in a
prone position with the head flexed below the hori-
zontal by approximately 30°. With the aid of a Zeiss
OPM 212–7 operating microscope (Zeiss, Oberkochen,
Germany), the C1 and C2 laminae were exposed after
dissection of the muscle layers. After C1–C2 laminec-
tomy and longitudinal opening of the dura, the arach-
noid and septum posticum were incised using a 30-
gauge needle. The exact midline of the spinal cord was
determined by measuring midway between the two
root entry zones. With the aid of the operating micro-
scope and after deposition of the dorsal vein, CPMM
was performed at C1–C2 using a 30-gauge needle with
a mark 1 mm from the beveled tip. Midline punctate
was performed in the sagittal plane of the median
septum to a depth of 1 mm. The incision was closed
with sutures once hemostasis was achieved. The en-
tire procedure was completed within approximately
15–20 minutes. After surgery, animals were moni-
tored closely for respiratory distress. Body tempera-
ture was maintained at 37 ± 1°C until the animals were
fully awake from the anesthesia. In the sham group,
animals underwent C1–C2 laminectomy without CPMM.
Behavioral tests
Each mouse was placed in a 30 x 30 x 30 cm
polypropylene box and initially allowed 30 minutes to
get used to its surroundings. Behavioral investigators
were blinded to the treatment groups. Twenty-four
hours after surgery, animals were intraperitoneally
injected with 0.6% acetic acid (0.1 ml/10 g) in the left
lower quadrant of the abdomen. Visceral pain-related
behaviors (licking abdomen, stretching, contraction of
abdomen, and so on) were counted between 5 and 20
minutes after injection.
Statistical analysis
Group data are expressed as mean ± standard devia-
tion of the mean. For group comparisons, analysis of
variance was performed with Bonferroni post-hoc tests.
Differences were considered statistically significant at
p values of less than 0.05.
RESULTS
None of the 24 animals undergoing surgery died or
had neurologic deficits. Writhing test scores were not
significantly different between Groups 1 (56.7 ± 10.7)
and 3 (50.7 ± 17.4). However, Group 2 showed more
than 40% antinociception after treatment (30.0 ± 14.3),
which was significantly different from the scores in
the other two groups (p < 0.001).
DISCUSSION
Visceral pain in patients with advanced cancer is dif-
ficult to control with either medication or surgery.
Commissural myelotomy is relatively effective for
midline pain of several spinal segments, but it has
significant complications including a decrease in
proprioception, dysesthesia, transient paresis, sphinc-
ter dysfunction, and even death [14]. The poor locali-
zation of spinal segments responsible for visceral pain
and the increased surgical risk of extended commis-
surotomy of more than four segments also limit the
use of midline commissural myelotomy. Limited mid-
line myelotomy at C1, introduced by Hitchcock [8], is
performed stereotactically and has surprisingly wide-
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spread visceral pain relief. In order to reduce the risk
of respiratory complications and upper limb sequelae,
the spinal cord is placed under direct visual control [9,
10,15]. CPMM at the thoracic cord also provides sur-
prisingly widespread visceral pain relief while de-
creasing proprioceptive or other complications [9–13,
15]. In mice with experimental pancreatitis, dorsal
column lesions at C1 could reverse the reduction in
homecage activity [16]. This implies that dorsal col-
umn lesions are involved in transmitting nociceptive
signals from the pancreas to the brain. Taking these
findings together, the dorsal column may be the major
pathway of visceral pain. Theoretically, a midline
lesion would interrupt the visceral pathways that
enter and ascend from the spinal cord below the lesion.
Our results showed satisfactory relief of visceral
pain by CPMM. Mice undergoing CPMM had more
than 40% antinociception after treatment, with signifi-
cantly different writhing test scores compared with
control and sham groups. CPMM is a simple, effective,
and sa fe  procedure .  Al though CPMM is  a
neuroablative procedure and adverse complications
or sequelae may occur, our method did not result in
any obvious neurologic complications. CPMM may
enable cancer patients to tolerate severe cancer pain
and provide them with a better quality of life. Our
results also confirmed that there is a posterior column
sensory pathway that mediates visceral pain.
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